Home › Funds › TCG Crossover Management, LLC › LBRX
TCG Crossover Management, LLC position in LBRX
LB PHARMACEUTICALS INC · Health Care
TCG Crossover Management, LLC reported holding 765,050 shares of LBRX (LB PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$29.4M, representing 0.83% of its reported portfolio and ranking #33 among its reported holdings. TCG Crossover Management, LLC has disclosed LBRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How TCG Crossover Management, LLC's LBRX position evolved
TCG Crossover Management, LLC first disclosed a stake in LBRX in Q3 2025 at 1,745,016 shares (US$27.6M). The position peaked in Q2 2026 at 1,447,310 shares, worth US$47.0M. Across 5 filings, TCG Crossover Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 765,050 shares valued at US$29.4M — a reduction of -682,260 shares quarter over quarter.. Notable position changes include a 47% trim in Q3 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.75M | $27.55M | New |
| Q4 2025 | 1.75M | $38.84M | Hold |
| Q1 2026 | 1.84M | $45.28M | Add |
| Q2 2026 | 1.45M | $46.97M | Reduce |
| Q3 2026 | 765.05K | $29.36M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LBRX and 13F data
LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 107 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$128.7M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Spruce Street Capital LP (US$53.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LBRX
- Deep Track Capital, LP 3.35M sh · $128.68M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 2.21M sh · $71.68M · Q2 2026
- Spruce Street Capital LP 1.40M sh · $53.86M · Q3 2026
- Commodore Capital LP 1.50M sh · $48.68M · Q2 2026
- Caligan Partners LP 1.44M sh · $46.67M · Q2 2026
- Trails Edge Capital Partners, LP 1.15M sh · $44.11M · Q3 2026
- Nantahala Capital Management, LLC 1.07M sh · $41.23M · Q3 2026
- Vivo Capital, LLC 800.00K sh · $30.70M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 741.41K sh · $28.46M · Q3 2026
- Nan Fung Group Holdings Ltd 630.66K sh · $24.20M · Q3 2026
- Integral Health Asset Management, LLC 470.00K sh · $18.04M · Q3 2026
- GREAT POINT PARTNERS LLC 317.22K sh · $10.30M · Q2 2026
More on TCG Crossover Management, LLC
FAQ
How long has TCG Crossover Management, LLC held LBRX?
TCG Crossover Management, LLC has disclosed LBRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is TCG Crossover Management, LLC's current position in LBRX?
As of Q3 2026, TCG Crossover Management, LLC holds 765.05K shares of LBRX (LB PHARMACEUTICALS INC), valued at $29.36M, representing 0.83% of its reported portfolio and ranking #33.
Has TCG Crossover Management, LLC been buying or selling LBRX?
In the latest 13F filing (Q3 2026), TCG Crossover Management, LLC reduced its position in LBRX. The position peaked in Q2 2026 at 1.45M shares.
Which other funds hold LBRX?
Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Spruce Street Capital LP, among 107 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.